132 related articles for article (PubMed ID: 28562099)
1. The effectiveness of transdermal testosterone gel 1% (androgel) for poor responders undergoing in vitro fertilization.
Doan HT; Quan LH; Nguyen TT
Gynecol Endocrinol; 2017 Dec; 33(12):977-979. PubMed ID: 28562099
[TBL] [Abstract][Full Text] [Related]
2. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis.
González-Comadran M; Durán M; Solà I; Fábregues F; Carreras R; Checa MA
Reprod Biomed Online; 2012 Nov; 25(5):450-9. PubMed ID: 22999555
[TBL] [Abstract][Full Text] [Related]
3. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
4. Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders--an observational pilot study.
Mitri F; Behan LA; Murphy CA; Hershko-Klement A; Casper RF; Bentov Y
Fertil Steril; 2016 Jan; 105(1):100-5.e1-6. PubMed ID: 26496380
[TBL] [Abstract][Full Text] [Related]
5. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
Bosdou JK; Venetis CA; Dafopoulos K; Zepiridis L; Chatzimeletiou K; Anifandis G; Mitsoli A; Makedos A; Messinis IE; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2016 May; 31(5):977-85. PubMed ID: 26956551
[TBL] [Abstract][Full Text] [Related]
6. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.
Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A
Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834
[TBL] [Abstract][Full Text] [Related]
7. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
8. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
Bosdou JK; Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Zepiridis L; Tarlatzis BC
Hum Reprod Update; 2012; 18(2):127-45. PubMed ID: 22307331
[TBL] [Abstract][Full Text] [Related]
9. Impact of the number of retrieved oocytes on pregnancy outcome in in vitro fertilization.
Hsu MI; Wang CW; Chen CH; Tzeng CR
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):821-825. PubMed ID: 28040127
[TBL] [Abstract][Full Text] [Related]
10. Androgen supplementation in IVF.
Kim CH
Minerva Ginecol; 2013 Oct; 65(5):497-504. PubMed ID: 24096287
[TBL] [Abstract][Full Text] [Related]
11. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.
Caprio F; D'Eufemia MD; Trotta C; Campitiello MR; Ianniello R; Mele D; Colacurci N
J Ovarian Res; 2015 Jun; 8():37. PubMed ID: 26067283
[TBL] [Abstract][Full Text] [Related]
12. Serum Stem Cell Factor Assay in Elderly Poor Responder Patients Undergoing IVF: A New Biomarker to Customize Follicle Aspiration Cycle by Cycle.
Gizzo S; Quaranta M; Andrisani A; Bordin L; Vitagliano A; Esposito F; Venturella R; Zicchina C; Gangemi M; Noventa M
Reprod Sci; 2016 Jan; 23(1):61-8. PubMed ID: 26156851
[TBL] [Abstract][Full Text] [Related]
13. Higher live birth rate following transdermal testosterone pretreatment in poor responders: a systematic review and meta-analysis.
Katsika ET; Bosdou JK; Goulis DG; Grimbizis GF; Kolibianakis EM
Reprod Biomed Online; 2023 Jan; 46(1):81-91. PubMed ID: 36369150
[TBL] [Abstract][Full Text] [Related]
14. Embryo quality in controlled ovarian stimulation for in vitro fertilization in young poor responders.
Almog B; Eldar I; Barkan G; Amit A; Wagman I; Levin I
Gynecol Endocrinol; 2014 Sep; 30(9):657-9. PubMed ID: 24845413
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
Balasch J; Fábregues F; Peñarrubia J; Carmona F; Casamitjana R; Creus M; Manau D; Casals G; Vanrell JA
Hum Reprod; 2006 Jul; 21(7):1884-93. PubMed ID: 16517559
[TBL] [Abstract][Full Text] [Related]
16. Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment.
Sunkara SK; Coomarasamy A
Fertil Steril; 2011 Jun; 95(8):e73-4; author reply e75. PubMed ID: 21601849
[No Abstract] [Full Text] [Related]
17. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study.
Massin N; Cedrin-Durnerin I; Coussieu C; Galey-Fontaine J; Wolf JP; Hugues JN
Hum Reprod; 2006 May; 21(5):1204-11. PubMed ID: 16476678
[TBL] [Abstract][Full Text] [Related]
18. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
[TBL] [Abstract][Full Text] [Related]
19. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders.
Kim CH; Howles CM; Lee HA
Fertil Steril; 2011 Feb; 95(2):679-83. PubMed ID: 20801436
[TBL] [Abstract][Full Text] [Related]
20. Effects of triploidy incidence on clinical outcomes for IVF-ET cycles in different ovarian stimulation protocols.
Li M; Xue X; Zhang S; Li W; Zhao X; Ren W; Shi J
Gynecol Endocrinol; 2015 Oct; 31(10):769-73. PubMed ID: 26220642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
